Products and services
HCMV and MCMV antibodies
The Center for Proteomics provides the possibility of generating target proteins as an essential component of the monoclonal antibody development process. The standard expression technology is based on E. coli and baculovirus.
The number of generated hybridoma cell lines per antigen is flexible. Also, we can select the most productive and stable hybridoma cell clones based on the techniques in accordance with the customer needs, or a higher number of mAbs can be tested by the customer before the decision. Hybridoma cell lines adaptation to the serum-free media is also possible.
Papain or pepsin fragmentation of antibodies is available resulting in Fab' or F(ab')2 fragments. Customer gets an expertise regarding the host and the isotype of the chosen IgG as well as the most reliable products of defined quality.
|
||||||||||||||||||||||||||||||||||||
Find out what is new! Learn all about the Center for Proteomics' dissemination activities here.
Antibody engineering: from murine hybridoma to therapeutics - 3rd CAPRI2010 Advanced Laboratory Workshop
University of Rijeka Faculty of Medicine, 13 - 15 February 2012

More details can be found here.